When two is better than three: Dual antithrombotic therapy cuts bleeding risk

Clinical trial finds that dabigatran dual therapy after stenting reduced bleeding risk for patients with atrial fibrillation compared with standard triple therapy.

from Top Health News – ScienceDaily http://ift.tt/2wJYxa1
from Tumblr http://ift.tt/2xohEDl